Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

HAE holding history

Haemonetics Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HAE overviewAll 13F holders of HAEFull Q2 2026 holdings

Shares (Q2 2026)
36,040
Value
$2.70M
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of HAE by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202636,040$2.70M<0.1%−154,610−81.1%ReducedHolders
Q1 2026190,650$10.7M<0.1%+59,173+45.0%AddedHolders
Q4 2025131,477$10.5M<0.1%+131,477NewHolders
Q1 20250$00.0%−18,237−100.0%Sold outHolders
Q4 202418,237$1.42M<0.1%+18,237NewHolders
Q3 20240$00.0%−140,264−100.0%Sold outHolders
Q2 2024140,264$11.6M<0.1%+104,849+296.1%AddedHolders
Q1 202435,415$3.02M<0.1%+7,160+25.3%AddedHolders
Q4 202328,255$2.42M<0.1%−1,153−3.9%ReducedHolders
Q3 202329,408$2.63M<0.1%+1,651+5.9%AddedHolders
Q2 202327,757$2.36M<0.1%−82−0.3%ReducedHolders
Q1 202327,839$2.30M<0.1%+27,839NewHolders
Q4 20220$00.0%−7,998−100.0%Sold outHolders
Q3 20227,998$592.0K<0.1%−32,820−80.4%ReducedHolders
Q2 202240,818$2.66M<0.1%−133,304−76.6%ReducedHolders
Q1 2022174,122$11.0M<0.1%−16,589−8.7%ReducedHolders
Q4 2021190,711$10.1M<0.1%−68,911−26.5%ReducedHolders
Q3 2021259,622$18.3M<0.1%−256,145−49.7%ReducedHolders
Q2 2021515,767$34.4M<0.1%+399,381+343.2%AddedHolders
Q1 2021116,386$12.9M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.